BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11746969)

  • 1. Bovine oocytes treated prior to in vitro maturation with a combination of butyrolactone I and roscovitine at low doses maintain a normal developmental capacity.
    Ponderato N; Lagutina I; Crotti G; Turini P; Galli C; Lazzari G
    Mol Reprod Dev; 2001 Dec; 60(4):579-85. PubMed ID: 11746969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonic and foetal development of bovine oocytes treated with a combination of butyrolactone I and roscovitine in an enriched medium prior to IVM and IVF.
    Ponderato N; Crotti G; Turini P; Duchi R; Galli C; Lazzari G
    Mol Reprod Dev; 2002 Aug; 62(4):513-8. PubMed ID: 12112585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Temporary Meiotic Attenuation of Oocytes with Butyrolactone I and Roscovitine in Resistance to Bovine Embryos on Vitrification.
    Maziero RR; Guaitolini CR; Paschoal DM; Kievitsbosch T; Guastali MD; Moraes CN; Landim-Alvarenga FC
    Reprod Domest Anim; 2016 Apr; 51(2):204-11. PubMed ID: 26812982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meiotic inhibition with different cyclin-dependent kinase inhibitors in bovine oocytes and its effects on maturation and embryo development.
    Adona PR; Lima Verde Leal C
    Zygote; 2004 Aug; 12(3):197-204. PubMed ID: 15521709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with roscovitine and butyrolactone I prior to
    Maziero RRD; Guaitolini CRF; Paschoal DM; Crespilho AM; Monteiro BA; Lima JS; Sestari DAO; Landim-Alvarenga FDC
    Zygote; 2020 Feb; 28(1):24-31. PubMed ID: 31603065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine oocyte and embryo development following meiotic inhibition with butyrolactone I.
    Lonergan P; Dinnyes A; Fair T; Yang X; Boland M
    Mol Reprod Dev; 2000 Oct; 57(2):204-9. PubMed ID: 10984421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High developmental competence of cattle oocytes maintained at the germinal vesicle stage for 24 hours in culture by specific inhibition of MPF kinase activity.
    Mermillod P; Tomanek M; Marchal R; Meijer L
    Mol Reprod Dev; 2000 Jan; 55(1):89-95. PubMed ID: 10602278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear maturation kinetics and in vitro embryo development of cattle oocytes prematured with butyrolactone I combined or not combined with roscovitine.
    Adona PR; Pires PR; Quetglas MD; Schwarz KR; Leal CL
    Anim Reprod Sci; 2008 Mar; 104(2-4):389-97. PubMed ID: 17644285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prematuration, meiosis activating sterol and enriched maturation medium on the nuclear maturation and competence to development of calf oocytes.
    Donnay I; Faerge I; Grøndahl C; Verhaeghe B; Sayoud H; Ponderato N; Galli C; Lazzari G
    Theriogenology; 2004 Sep; 62(6):1093-107. PubMed ID: 15289049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of roscovitine on the nuclear and cytoskeletal components of calf oocytes and their subsequent development.
    Albarracín JL; Morató R; Izquierdo D; Mogas T
    Theriogenology; 2005 Nov; 64(8):1740-55. PubMed ID: 15936813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural modifications in bovine oocytes maintained in meiotic arrest in vitro using roscovitine or butyrolactone.
    Lonergan P; Faerge I; Hyttel PM; Boland M; Fair T
    Mol Reprod Dev; 2003 Mar; 64(3):369-78. PubMed ID: 12548669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prematuration of bovine oocytes with butyrolactone I: effects on meiosis progression, cytoskeleton, organelle distribution and embryo development.
    Adona PR; Pires PR; Quetglas MD; Schwarz KR; Leal CL
    Anim Reprod Sci; 2008 Oct; 108(1-2):49-65. PubMed ID: 17692479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrolactone I reversibly alters nuclear configuration, periooplasmic microtubules and development of porcine oocytes.
    Weng YC; Sha SW; Chiou CM; Tang PC; Yang JH; Ju JC
    Theriogenology; 2007 Feb; 67(3):509-19. PubMed ID: 17030361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronisation of canine germinal vesicle stage oocytes prior to in vitro maturation alters the kinetics of nuclear progression during subsequent resumption of meiosis.
    Hanna C; Menges S; Kraemer D; Long CR
    Reprod Fertil Dev; 2008; 20(5):606-14. PubMed ID: 18577358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrolactone I reversibly inhibits meiotic maturation of bovine oocytes,Without influencing chromosome condensation activity.
    Kubelka M; Motlík J; Schultz RM; Pavlok A
    Biol Reprod; 2000 Feb; 62(2):292-302. PubMed ID: 10642565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of roscovitine on nuclear maturation, MPF and MAP kinase activity and embryo development of prepubertal goat oocytes.
    Jimenez-Macedo AR; Izquierdo D; Urdaneta A; Anguita B; Paramio MT
    Theriogenology; 2006 Jun; 65(9):1769-82. PubMed ID: 16297445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the efficiency and reversibility of roscovitine (ROS) block on the meiotic resumption of goat oocytes.
    Han D; Lan GC; Wu YG; Han ZB; Wang HL; Tan JH
    Mol Reprod Dev; 2006 Feb; 73(2):238-46. PubMed ID: 16250008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High developmental competence of pig oocytes after meiotic inhibition with a specific M-phase promoting factor kinase inhibitor, butyrolactone I.
    Wu GM; Sun QY; Mao J; Lai L; McCauley TC; Park KW; Prather RS; Didion BA; Day BN
    Biol Reprod; 2002 Jul; 67(1):170-7. PubMed ID: 12080014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations and reversibility in the chromatin, cytoskeleton and development of pig oocytes treated with roscovitine.
    Ju JC; Tsay C; Ruan CW
    Mol Reprod Dev; 2003 Apr; 64(4):482-91. PubMed ID: 12589660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitrification of calf oocytes: effects of maturation stage and prematuration treatment on the nuclear and cytoskeletal components of oocytes and their subsequent development.
    Albarracín JL; Morató R; Izquierdo D; Mogas T
    Mol Reprod Dev; 2005 Oct; 72(2):239-49. PubMed ID: 15968627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.